title: Fluconazole: Pfizer asked to lower Africa price.
abstract: Pfizer, Inc.'s fluconazole costs almost 15 times as much in South Africa, where it is patent protected, than in Thailand where it is generic. The result is that many Africans die of cryptococcal meningitis and other fungal infections because they cannot obtain the patented drug at Pfizer's price. In South Africa, a coalition of major organizations has asked Pfizer to either reduce the price to the Thailand level, or voluntarily license the patent to that the treatment could be made available.
authors.forename: J S
authors.initials: JS
authors.lastname: James
mesh_terms: D000349:Africa; D000935:Antifungal Agents / Q000191:economics* / Q000600:supply & distribution; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics*; D015725:Fluconazole / Q000191:economics* / Q000600:supply & distribution; D006801:Humans
chemical_list: D000935:Antifungal Agents; D015725:Fluconazole